Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPV-specific antibody status in oral fluids after quadrivalent HPV vaccine (Gardasil)
2008-008605-22Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Feb 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of qHPV vaccine in human papillomavirus infection, anogenital dysplasia, anogenital warts and 1 more, sponsored by Medical University of Vienna. Primary endpoints: HPV-specific antibody status in serum after Gardasil vaccination, HPV-specific antibody status in oral fluids after Gardasil vaccination and 1 more. Started Feb 2009; status: completed.
02
Drugs
qHPV vaccine
03
Conditions
human papillomavirus infectionanogenital dysplasiaanogenital wartscervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on 2008-008605-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008605-22.